Comparison of the Effect of MFAT and MFAT + PRP on Treatment of Hip Osteoarthritis: An Observational, Intention-to-Treat Study at One Year.
Nima HeidariMark SlevinYasmin ZeinolabedinyDavide MeloniStefano OlgiatiAdrian WilsonAli NooraniLeonard AzamfireiPublished in: Journal of clinical medicine (2022)
Hip osteoarthritis (OA) is a major contributor to reduced quality of life and concomitant disability associated with lost working life months. Intra-articular injection of various biological materials has shown promise in alleviating symptoms and potentially slowing down the degenerative process. Here, we compared the effects of treatment of a cohort of 147 patients suffering from grade 1-4 hip OA; with either micro-fragmented adipose tissue (MFAT), or a combination of MFAT with platelet-rich plasma (PRP). We found significant improvements in both the visual analogue score for pain (VAS) and Oxford hip score (OHS) that were similar for both treatments with over 60% having an improvement in the VAS score of 20 points or more. These results suggest a positive role for intra-articular injection of MFAT + PRP as a treatment for hip osteoarthritis which may be important particularly in low body mass index (BMI) patients where the difficulty in obtaining sufficient MFAT for treatment could be offset by using this combination of biologicals.
Keyphrases
- platelet rich plasma
- body mass index
- adipose tissue
- end stage renal disease
- ejection fraction
- rheumatoid arthritis
- chronic kidney disease
- newly diagnosed
- type diabetes
- total hip arthroplasty
- chronic pain
- physical activity
- combination therapy
- metabolic syndrome
- skeletal muscle
- depressive symptoms
- spinal cord injury
- big data
- patient reported outcomes
- pain management
- artificial intelligence
- deep learning
- smoking cessation
- weight loss
- cross sectional
- patient reported